Penserra Capital Management LLC United Therapeutics Corp Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$228.26 - $319.04 $632,736 - $884,378
2,772 New
2,772 $883,000
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $444,017 - $612,495
2,540 New
2,540 $598,000
Q4 2020

Feb 12, 2021
SELL
$101.87 - $151.79 $38,710 - $57,680
-380 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $37,962 - $46,029
380 New
380 $38,000

Others Institutions Holding UTHR

# of Institutions
668
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email